Prestwick Chemical

Illkirch-graffenstaden, France Founded: 1999 • Age: 27 yrs Acquired By Domain Therapeutics
Provides chemical screening libraries and customized medicinal chemistry services to drug developers

About Prestwick Chemical

Prestwick Chemical is a Healthcare company based in Illkirch-graffenstaden (France) founded in 1999, and was acquired by Domain Therapeutics in December 2019. It provides chemical screening libraries and customized medicinal chemistry services to drug developers. Its chief executive, as recorded, is Deborah Rathjen. Prestwick Chemical offers products and services including Prestwick Chemical Library, Prestwick Oncombo Library, and Custom Synthesis. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry.

Company details

Prestwick Chemical is a French CRO. It offers chemical screening libraries and customised medicinal chemistry services to accelerate early drug development. It provides medchem services such as hit discovery, hit validation, hit-to-lead, lead optimization, computational chemistry and custom synthesis services. Prestwicks chemical libraries can be used to find stem cell growth modulators and also for Repurposing Repositioning. It claims that it has helped in bringing 1 NCE to the market, also in bringing 10 NCEs to the clinic and 8 are currently in the preclinical phase.

Key Metrics

Products & Services of Prestwick Chemical

Prestwick Chemical offers a comprehensive portfolio of products and services, including Prestwick Chemical Library, Prestwick Oncombo Library, and Custom Synthesis.

Prestwick Chemical Library
Screening Library

Collection of 1760 FDA-approved drugs for early drug discovery screening.

Prestwick Oncombo Library
Screening Library

Specialized library for combination drug testing in research.

Custom Synthesis
Service Offering

Provides analogues and original compounds for drug development needs.

Investors in Prestwick Chemical

Prestwick Chemical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Domain Therapeutics.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
GPCR-targeted drug candidates for immuno-oncology and inflammation are developed.
2008domaintherapeutics.comStrasbourg, France
Premium access

Investor details for Prestwick Chemical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Prestwick Chemical

1 people are tracked at Prestwick Chemical (1 in leadership).

NameRoleGroup
Deborah Rathjen
CEOLeadership
Premium access

Complete people profiles for Prestwick Chemical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Prestwick Chemical

2 dated milestones of Prestwick Chemical across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded Prestwick Chemical is founded.
  2. Exit Acquired by Domain Therapeutics.

Web traffic of Prestwick Chemical

The website of Prestwick Chemical (prestwickchemical.com) receives about 1.7K visits a month.

  • Monthly visits
    1.7K

    ▲ 24.5% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Prestwick Chemical

Premium access

Complete news archive for Prestwick Chemical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prestwick Chemical

Prestwick Chemical was founded in 1999.

Prestwick Chemical is headquartered in Illkirch-graffenstaden, France. It is registered at Illkirch-graffenstaden, Bas-rhin, France.

Deborah Rathjen is the CEO of Prestwick Chemical, as recorded in our data.

Prestwick Chemical is a French CRO. It offers chemical screening libraries and customised medicinal chemistry services to accelerate early drug development. It provides medchem services such as hit discovery, hit validation, hit-to-lead, lead optimization, computational chemistry and custom synthesis services. Prestwicks chemical libraries can be used to find stem cell growth modulators and also for Repurposing Repositioning. It claims that it has helped in bringing 1 NCE to the market, also in bringing 10 NCEs to the clinic and 8 are currently in the preclinical phase.

Prestwick Chemical offers Prestwick Chemical Library, Prestwick Oncombo Library, and Custom Synthesis.

Prestwick Chemical has 1 investor. Key investors include Domain Therapeutics.

Yes. Prestwick Chemical was acquired by Domain Therapeutics in December 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available